Literature DB >> 33654962

Induction and Analysis of Anti-CD40-induced Colitis in Mice.

Barbara Joyce-Shaikh1, Daniel J Cua1, David Bauché1.   

Abstract

Colon inflammation or colitis affects more than 1 million people worldwide. Several pre-clinical models, including chemical-induced (i.e., DSS, TNBS) or pathogen-induced (i.e., Citrobacter rodentium) have been used to study mechanisms involved in the development and regulation of colitis. Anti-CD40 induced colitis model has gained acceptance to study the roles of innate immune cells during acute intestinal inflammation. Here we describe a rapid, robust and reproducible protocol to induce and analyze anti-CD40 mediated colitis in mice.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Anti-CD40; Colitis; IBD; IL-22; IL-23; Inflammation; Innate immunity

Year:  2019        PMID： 33654962      PMCID： PMC7854191          DOI： 10.21769/BioProtoc.3153

Source DB:  PubMed          Journal:  Bio Protoc        ISSN： 2331-8325


  5 in total

1.  Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.

Authors:  Holm H Uhlig; Brent S McKenzie; Sophie Hue; Claire Thompson; Barbara Joyce-Shaikh; Renata Stepankova; Nicolas Robinson; Sofia Buonocore; Helena Tlaskalova-Hogenova; Daniel J Cua; Fiona Powrie
Journal:  Immunity       Date:  2006-08       Impact factor: 31.745

2.  LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis.

Authors:  David Bauché; Barbara Joyce-Shaikh; Renu Jain; Jeff Grein; Karin S Ku; Wendy M Blumenschein; Stephanie C Ganal-Vonarburg; Douglas C Wilson; Terrill K McClanahan; Rene de Waal Malefyt; Andrew J Macpherson; Lakshmanan Annamalai; Jennifer H Yearley; Daniel J Cua
Journal:  Immunity       Date:  2018-08-07       Impact factor: 31.745

Review 3.  Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.

Authors:  Siew C Ng; Hai Yun Shi; Nima Hamidi; Fox E Underwood; Whitney Tang; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Justin C Y Wu; Francis K L Chan; Joseph J Y Sung; Gilaad G Kaplan
Journal:  Lancet       Date:  2017-10-16       Impact factor: 79.321

4.  Muscle Histology Characterization Using H&E Staining and Muscle Fiber Type Classification Using Immunofluorescence Staining.

Authors:  Chao Wang; Feng Yue; Shihuan Kuang
Journal:  Bio Protoc       Date:  2017-05-20

5.  Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease.

Authors:  Corinne Cayatte; Barbara Joyce-Shaikh; Felix Vega; Katia Boniface; Jeffrey Grein; Erin Murphy; Wendy M Blumenschein; Smiley Chen; Maria-Christina Malinao; Beth Basham; Robert H Pierce; Edward P Bowman; Brent S McKenzie; Charles O Elson; William A Faubion; Rene de Waal Malefyt; Robert A Kastelein; Daniel Cua; Terrill K McClanahan; Maribel Beaumont
Journal:  Clin Transl Gastroenterol       Date:  2012-02-16       Impact factor: 4.488
  5 in total
  2 in total

1.  Bacteroides ovatus Promotes IL-22 Production and Reduces Trinitrobenzene Sulfonic Acid-Driven Colonic Inflammation.

Authors:  Faith D Ihekweazu; Melinda A Engevik; Wenly Ruan; Zhongcheng Shi; Robert Fultz; Kristen A Engevik; Alexandra L Chang-Graham; Jasmin Freeborn; Evelyn S Park; Susan Venable; Thomas D Horvath; Sigmund J Haidacher; Anthony M Haag; Annie Goodwin; Deborah A Schady; Joseph M Hyser; Jennifer K Spinler; Yuying Liu; James Versalovic
Journal:  Am J Pathol       Date:  2021-01-28       Impact factor: 4.307

2.  NFAM1 Promotes Pro-Inflammatory Cytokine Production in Mouse and Human Monocytes.

Authors:  Kathryn W Juchem; Anshu P Gounder; Jian Ping Gao; Elise Seccareccia; Narayana Yeddula; Nicholas J Huffmaster; Alexandra Côté-Martin; Steven E Fogal; Donald Souza; Sarah Sirui Wang; Elizabeth R A Glynn; Ivy Yung; Julie Ritchie; Li Li; Jie Zheng; M Lamine Mbow; Jun Li; Sumit K Chanda
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.